Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
63.52
+1.24 (1.99%)
Oct 22, 2026, 4:00 PM EDT - Market closed
ESTA Revenue
Establishment Labs Holdings had revenue of $67.54M in the quarter ending June 30, 2026, with 31.66% growth. This brings the company's total for the last twelve months to $245.82M, up 38.55% year-over-year. In the year 2025, Establishment Labs Holdings had annual revenue of $211.08M with 27.14% growth. That makes Establishment Labs Holdings the 15,946th largest company in the world by revenue and 2,748th in the United States.
Revenue (ttm)
$245.82M
Revenue Growth
+38.55%
P/S Ratio
7.70
Revenue / Employee
$244,839
Employees
1,004
Market Cap
1.89B
Revenue by Geography
- EMEA (Europe / Middle East / Africa) 91.05M 43.1%
- North America 45.56M 21.6%
- Latin America 39.93M 18.9%
- Asia-Pacific 34.54M 16.4%
Fiscal year ended Dec 31, 2025 See the full ESTA breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 211.08M | 45.05M | 27.14% |
| Dec 31, 2024 | 166.03M | 874.00K | 0.53% |
| Dec 31, 2023 | 165.15M | 3.45M | 2.13% |
| Dec 31, 2022 | 161.70M | 35.02M | 27.64% |
| Dec 31, 2021 | 126.68M | 42.01M | 49.61% |
| Dec 31, 2020 | 84.68M | -4.89M | -5.46% |
| Dec 31, 2019 | 89.57M | 28.36M | 46.33% |
| Dec 31, 2018 | 61.21M | 26.53M | 76.49% |
| Dec 31, 2017 | 34.68M | 14.88M | 75.15% |
| Dec 31, 2016 | 19.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.30B |
| CONMED | 1.37B |
| Inspire Medical Systems | 898.74M |
| Neogen | 884.00M |
| Alphatec Holdings | 815.05M |
| NovoCure | 699.19M |
| TransMedics Group | 668.47M |
| UFP Technologies | 631.64M |
ESTA News
- 3 days ago - Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29 - Business Wire
- 8 days ago - Establishment Labs initiated with a Buy at Stifel - TheFly
- 17 days ago - Establishment Labs receive FDA approval for additional sizes of Motiva Implants - TheFly
- 17 days ago - Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants® - Business Wire
- 4 weeks ago - Establishment Labs highlights breast tissue preservation data - TheFly
- 4 weeks ago - Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants - Business Wire
- 2 months ago - Establishment Labs upgraded to Buy from Neutral at Citi - TheFly
- 2 months ago - Citi upgrades Establishment Labs to Buy on recent pullback - TheFly